Want to join the conversation?
Pharma giant $MDT said it has received U.S. Food and Drug Administration (FDA) approval for its MiniMed 670G hybrid closed loop system. This is the first FDA-approved device that is intended to automatically monitor glucose and provide appropriate basal insulin doses for people with type 1 diabetes.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.